InsiderSource
VOR

Vor Biopharma Inc.

SEC CIK 1817229
$15.02 +14.0% · 90 days
90-day buys
$0
0 open-market
90-day sells
$49.42M
15 open-market
Net insider flow
−$49.42M
Net selling
Filings shown
15
Most recent
Advertisement

At a glance

Over the last 90 days, insiders at VOR have sold a net $49.42M of stock (0 open-market buys vs 15 sells).

Largest recent trade: Ra Capital Management, L.p. sold $8.88M of VOR, trimming their stake 10%.

Most active filer: Ra Capital Management, L.p., with 15 transactions among the recent filings shown.

Insider transaction history

Form 4 filings for VOR, newest first
View on SEC EDGAR ↗
VOR
Vor Biopharma Inc.
Sell RA CAPITAL MANAGEMENT, L.P.★ 17% · Director, 10% Owner · Open-market sale · filed Apr 24, 2026 ΔOwn −6.4%

Ra Capital Management, L.p. sold $2.6M of VOR, trimming their stake 6%.

−$2.6M
165,150 sh @ $16
VOR
Vor Biopharma Inc.
Sell RA CAPITAL MANAGEMENT, L.P.★ 17% · Director, 10% Owner · Open-market sale · filed Apr 21, 2026 ΔOwn −6.3%

Ra Capital Management, L.p. sold $2.71M of VOR, trimming their stake 6%.

−$2.71M
171,963 sh @ $16
VOR
Vor Biopharma Inc.
Sell RA CAPITAL MANAGEMENT, L.P.★ 17% · Director, 10% Owner · Open-market sale · filed Apr 21, 2026 ΔOwn −14%

Ra Capital Management, L.p. sold $7.46M of VOR, trimming their stake 14%.

−$7.46M
458,411 sh @ $16
VOR
Vor Biopharma Inc.
Sell RA CAPITAL MANAGEMENT, L.P.★ 17% · Director, 10% Owner · Open-market sale · filed Apr 15, 2026 ΔOwn −1.6%

Ra Capital Management, L.p. sold $858.8K of VOR, trimming their stake 2%.

−$858.8K
53,644 sh @ $16
VOR
Vor Biopharma Inc.
Sell RA CAPITAL MANAGEMENT, L.P.★ 17% · Director, 10% Owner · Open-market sale · filed Apr 15, 2026 ΔOwn −4.5%

Ra Capital Management, L.p. sold $2.46M of VOR, trimming their stake 5%.

−$2.46M
153,735 sh @ $16
Advertisement
VOR
Vor Biopharma Inc.
Sell RA CAPITAL MANAGEMENT, L.P.★ 17% · Director, 10% Owner · Open-market sale · filed Apr 15, 2026 ΔOwn −13%

Ra Capital Management, L.p. sold $8.57M of VOR, trimming their stake 13%.

−$8.57M
530,610 sh @ $16
VOR
Vor Biopharma Inc.
Sell RA CAPITAL MANAGEMENT, L.P.★ 17% · Director, 10% Owner · Open-market sale · filed Apr 10, 2026 ΔOwn −3.3%

Ra Capital Management, L.p. sold $2.24M of VOR, trimming their stake 3%.

−$2.24M
135,201 sh @ $17
VOR
Vor Biopharma Inc.
Sell RA CAPITAL MANAGEMENT, L.P.★ 17% · Director, 10% Owner · Open-market sale · filed Apr 10, 2026 ΔOwn −7.8%

Ra Capital Management, L.p. sold $5.76M of VOR, trimming their stake 8%.

−$5.76M
353,242 sh @ $16
VOR
Vor Biopharma Inc.
Sell RA CAPITAL MANAGEMENT, L.P.★ 17% · Director, 10% Owner · Open-market sale · filed Apr 10, 2026 ΔOwn −3.1%

Ra Capital Management, L.p. sold $2.21M of VOR, trimming their stake 3%.

−$2.21M
130,862 sh @ $17
VOR
Vor Biopharma Inc.
Sell RA CAPITAL MANAGEMENT, L.P.★ 17% · Director, 10% Owner · Open-market sale · filed Apr 6, 2026 ΔOwn −10%

Ra Capital Management, L.p. sold $8.88M of VOR, trimming their stake 10%.

−$8.88M
537,754 sh @ $17
VOR
Vor Biopharma Inc.
Sell RA CAPITAL MANAGEMENT, L.P.★ 17% · Director, 10% Owner · Open-market sale · filed Apr 6, 2026 ΔOwn −1.0%

Ra Capital Management, L.p. sold $774.2K of VOR, trimming their stake 1%.

−$774.2K
44,728 sh @ $17
VOR
Vor Biopharma Inc.
Sell RA CAPITAL MANAGEMENT, L.P.★ 17% · Director, 10% Owner · Open-market sale · filed Apr 6, 2026 ΔOwn −4.8%

Ra Capital Management, L.p. sold $4.71M of VOR, trimming their stake 5%.

−$4.71M
258,475 sh @ $18
Advertisement

About VOR insider activity

This page tracks every recent Form 4 filed for Vor Biopharma Inc. with the U.S. Securities and Exchange Commission. Form 4 is the disclosure that company insiders — officers, directors, and holders of more than 10% of the stock — must file within two business days of buying or selling shares.

The summary above nets open-market purchases against open-market sales over the trailing 90 days. Open-market trades (codes P and S) tend to carry the most signal because they reflect a deliberate choice to put money in or take it out, as opposed to routine grants, option exercises, or tax-withholding events. Use the badges on each row to tell them apart, and always confirm details against the original filing before drawing conclusions.

Frequently asked questions

How often is VOR insider data updated?

Continuously. We read from SEC EDGAR, so new Form 4 filings for Vor Biopharma Inc. usually appear here within minutes of being accepted by the SEC.

What does "net insider flow" mean?

It is the total dollar value of open-market insider purchases minus open-market sales over the last 90 days. A positive number (green) means insiders bought more than they sold; a negative number (red) means the reverse.

Why do some rows show grants or option exercises instead of buys?

Insiders receive stock through compensation as well as buying it outright. Form 4 captures all of these. We label each transaction by its SEC code so you can focus on open-market activity if you prefer.

Is this investment advice?

No. InsiderSource presents public filing data for informational purposes only. Insider activity is one of many factors to consider and is never a recommendation to buy or sell.